Drug General Information (ID: DDILOM86ES)
  Drug Name Dapsone Drug Info Aminolevulinic acid Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiinflammatory Agents Malignancy Photosensitizers
  Structure

 Mechanism of Dapsone-Aminolevulinic acid Interaction (Severity Level: Major)
     Increased risk of photosensitivity reactions Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Dapsone Aminolevulinic acid
      Mechanism Photosensitivity reactions Photosensitivity reactions
      Key Mechanism Factor 1
Factor Name Photosensitivity reactions
Factor Description Drug-induced photosensitivity reactions occur when certain photosensitizing drugs cause unexpected sunburn or dermatitis (dry, bumpy or blistering rash) on sun-exposed skin (face, neck, arms, backs of hands, and often lower legs and feet). The rash may or may not be itchy.
      Mechanism Description
  • Increased risk of photosensitivity reactions by the combination of Dapsone and Aminolevulinic acid 

Recommended Action
      Management Photosensitizing agents (e.g., fluoroquinolones, phenothiazines, retinoids, sulfonamides, sulfonylureas, tetracyclines, thiazide diuretics, griseofulvin, St. John's wort) and topical preparations containing aminolevulinic acid should generally not be administered for 24 hours before and after oral administration of aminolevulinic acid.

References
1 Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
2 Product Information. Gleolan (aminolevulinic acid). NX Development Corp, Lexington, KY.